Extending the Applicability of and Chicken Chorioallantoic Membrane Assays to Study Cytostatic Activity in Neuroblastoma Cells

Overview

Journal Front Oncol

Specialty Oncology

Date 2021 Sep 20

PMID 34540673

Citations 14

Authors

Miguel Angel Merlos Rodrigo

Berta Casar

Hana Michalkova

Ana Maria Jimenez Jimenez

Zbynek Heger

Vojtech Adam

Affiliations

Soon will be listed here.

Abstract

Purpose: The chick chorioallantoic membrane (CAM) assay can provide an alternative versatile, cost-effective, and ethically less controversial model for reliable screening of drugs. In the presented work, we demonstrate that CAM assay ( and ) can be simply employed to delineate the effects of cisplatin (CDDP) and ellipticine (Elli) on neuroblastoma (Nbl) cells in terms of their growth and metastatic potential.

Methods: The Nbl UKF-NB-4 cell line was established from recurrent bone marrow metastases of high-risk Nbl (stage IV, amplification, 7q21 gain). and CAM assays were optimized to evaluate the antimetastatic activity of CDDP and Elli. Immunohistochemistry, qRT-PCR, and DNA isolation were performed.

Results: CAM assay was employed to study whether CDDP and Elli exhibit any inhibitory effects on growth of Nbl xenograft in CAM assay. Under the optimal conditions, Elli and CDDP exhibited significant inhibition of the size of the primary tumor. To study the efficiency of CDDP and Elli to inhibit primary Nbl tumor growth, intravasation, and extravasation in the organs, we adapted the CAM assay protocol. In CAM assay, both studied compounds (CDDP and Elli) exhibited significant ( < 0.001) inhibitory activity against extravasation to all investigated organs including distal CAM.

Conclusions: Taken together, CAM assay could be a helpful and highly efficient approach for high-throughput screening of libraries of compounds with expected anticancer activities.

Citing Articles

The Chick Chorioallantoic Membrane as a Xenograft Model for the Quantitative Analysis of Uveal Melanoma Metastasis in Multiple Organs.

Liu H, Tsimpaki T, Anastasova R, Bechrakis N, Fiorentzis M, Berchner-Pfannschmidt U Cells. 2024; 13(14.

PMID: 39056751 PMC: 11275209. DOI: 10.3390/cells13141169.

Metallothionein-3 is a multifunctional driver that modulates the development of sorafenib-resistant phenotype in hepatocellular carcinoma cells.

Rodrigo M, Michalkova H, Jimenez A, Petrlak F, Do T, Sivak L Biomark Res. 2024; 12(1):38.

PMID: 38594765 PMC: 11003176. DOI: 10.1186/s40364-024-00584-y.

Experimental Tumor Induction and Evaluation of Its Treatment in the Chicken Embryo Chorioallantoic Membrane Model: A Systematic Review.

Mesas C, Chico M, Doello K, Lara P, Moreno J, Melguizo C Int J Mol Sci. 2024; 25(2).

PMID: 38255911 PMC: 10815318. DOI: 10.3390/ijms25020837.

Enhancement of targeted therapy in combination with metformin on human breast cancer cell lines.

Mahmoudi G, Ehteshaminia Y, Kokhaei P, Jalali S, Jadidi-Niaragh F, Pagheh A Cell Commun Signal. 2024; 22(1):10.

PMID: 38167105 PMC: 10763326. DOI: 10.1186/s12964-023-01446-0.

Technical Implications of the Chicken Embryo Chorioallantoic Membrane Assay to Elucidate Neuroblastoma Biology.

Patino-Morales C, Jaime-Cruz R, Ramirez-Fuentes T, Villavicencio-Guzman L, Salazar-Garcia M Int J Mol Sci. 2023; 24(19).

PMID: 37834193 PMC: 10572838. DOI: 10.3390/ijms241914744.

References

Ganeshan V, Schor N . Pharmacologic management of high-risk neuroblastoma in children. Paediatr Drugs. 2011; 13(4):245-55. PMC: 4321778. DOI: 10.2165/11591630-000000000-00000. View

Ribatti D . The chick embryo chorioallantoic membrane (CAM) assay. Reprod Toxicol. 2016; 70:97-101. DOI: 10.1016/j.reprotox.2016.11.004. View

Tsai J, Yang J . Epithelial-mesenchymal plasticity in carcinoma metastasis. Genes Dev. 2013; 27(20):2192-206. PMC: 3814640. DOI: 10.1101/gad.225334.113. View

Mangir N, Raza A, Haycock J, Chapple C, MacNeil S . An Improved Methodology to Visualise Tumour Induced Changes in Vasculature Using the Chick Chorionic Allantoic Membrane Assay. In Vivo. 2018; 32(3):461-472. PMC: 6000782. DOI: 10.21873/invivo.11262. View

Fennell D, Summers Y, Cadranel J, Benepal T, Christoph D, Lal R . Cisplatin in the modern era: The backbone of first-line chemotherapy for non-small cell lung cancer. Cancer Treat Rev. 2016; 44:42-50. DOI: 10.1016/j.ctrv.2016.01.003. View

Mapanao A, Che P, Sarogni P, Sminia P, Giovannetti E, Voliani V . Tumor grafted - chick chorioallantoic membrane as an alternative model for biological cancer research and conventional/nanomaterial-based theranostics evaluation. Expert Opin Drug Metab Toxicol. 2021; 17(8):947-968. DOI: 10.1080/17425255.2021.1879047. View

Melaiu O, Chierici M, Lucarini V, Jurman G, Conti L, De Vito R . Cellular and gene signatures of tumor-infiltrating dendritic cells and natural-killer cells predict prognosis of neuroblastoma. Nat Commun. 2020; 11(1):5992. PMC: 7689423. DOI: 10.1038/s41467-020-19781-y. View

Dunker N, Jendrossek V . Implementation of the Chick Chorioallantoic Membrane (CAM) Model in Radiation Biology and Experimental Radiation Oncology Research. Cancers (Basel). 2019; 11(10). PMC: 6826367. DOI: 10.3390/cancers11101499. View

Yogev O, Almeida G, Barker K, George S, Kwok C, Campbell J . Modeling of Chemoresistant Neuroblastoma Provides New Insights into Chemorefractory Disease and Metastasis. Cancer Res. 2019; 79(20):5382-5393. DOI: 10.1158/0008-5472.CAN-18-2759. View

10.

Casar B, Rimann I, Kato H, Shattil S, Quigley J, Deryugina E . In vivo cleaved CDCP1 promotes early tumor dissemination via complexing with activated β1 integrin and induction of FAK/PI3K/Akt motility signaling. Oncogene. 2012; 33(2):255-68. PMC: 3931462. DOI: 10.1038/onc.2012.547. View

11.

Kunz P, Schenker A, Sahr H, Lehner B, Fellenberg J . Optimization of the chicken chorioallantoic membrane assay as reliable in vivo model for the analysis of osteosarcoma. PLoS One. 2019; 14(4):e0215312. PMC: 6464229. DOI: 10.1371/journal.pone.0215312. View

12.

Herrero A, Pinto A, Colon-Bolea P, Casar B, Jones M, Agudo-Ibanez L . Small Molecule Inhibition of ERK Dimerization Prevents Tumorigenesis by RAS-ERK Pathway Oncogenes. Cancer Cell. 2015; 28(2):170-82. DOI: 10.1016/j.ccell.2015.07.001. View

13.

Sys G, Lapeire L, Stevens N, Favoreel H, Forsyth R, Bracke M . The in ovo CAM-assay as a xenograft model for sarcoma. J Vis Exp. 2013; (77):e50522. PMC: 3845689. DOI: 10.3791/50522. View

14.

Jung J . Human tumor xenograft models for preclinical assessment of anticancer drug development. Toxicol Res. 2014; 30(1):1-5. PMC: 4007037. DOI: 10.5487/TR.2014.30.1.001. View

15.

Amoroso L, Erminio G, Makin G, Pearson A, Brock P, Valteau-Couanet D . Topotecan-Vincristine-Doxorubicin in Stage 4 High-Risk Neuroblastoma Patients Failing to Achieve a Complete Metastatic Response to Rapid COJEC: A SIOPEN Study. Cancer Res Treat. 2017; 50(1):148-155. PMC: 5784636. DOI: 10.4143/crt.2016.511. View

16.

Ribatti D, Tamma R . The chick embryo chorioallantoic membrane as an in vivo experimental model to study human neuroblastoma. J Cell Physiol. 2018; 234(1):152-157. DOI: 10.1002/jcp.26773. View

17.

Zhou X, Xu C, Wang J, Dai T, Ye Y, Cui Y . Metastasis-Associated in Colon Cancer-1 Associates With Poor Prognosis and Promotes Cell Invasion and Angiogenesis in Human Cervical Cancer. Int J Gynecol Cancer. 2015; 25(8):1353-63. PMC: 5106080. DOI: 10.1097/IGC.0000000000000524. View

18.

Ribatti D, Annese T, Tamma R . The use of the chick embryo CAM assay in the study of angiogenic activiy of biomaterials. Microvasc Res. 2020; 131:104026. DOI: 10.1016/j.mvr.2020.104026. View

19.

Johnsen J, Dyberg C, Fransson S, Wickstrom M . Molecular mechanisms and therapeutic targets in neuroblastoma. Pharmacol Res. 2018; 131:164-176. DOI: 10.1016/j.phrs.2018.02.023. View

20.

Pinto M, Ribeiro A, Conde I, Carvalho R, Paredes J . The Chick Chorioallantoic Membrane Model: A New In Vivo Tool to Evaluate Breast Cancer Stem Cell Activity. Int J Mol Sci. 2021; 22(1). PMC: 7795925. DOI: 10.3390/ijms22010334. View